| Literature DB >> 32648772 |
Brad Roadcap1, Azher Hussain1, Dan Dreyer1, Keynu Carter1, Neal Dube1, Yang Xu1, Melanie Anderson1, Erwin Berthier2, Faye Vazvaei1, Kevin Bateman1, Eric Woolf1.
Abstract
In this paper we show the application of the Tasso OnDemand™, a novel automated sample collection device, in conjunction with volumetric absorptive microsampling (VAMS) for the development of gefapixant, a P2X3 receptor antagonist currently under clinical development for the treatment of refractory and unexplained chronic cough and endometriosis-related pain. A LC-MS/MS bioanalytical method was developed and validated using VAMS to support this development program. This method was utilized in a drug-drug interaction study to establish a mathematical bridging relationship with data obtained from a validated plasma assay used to support the program. The VAMS bioanalytical method and the predictability of the mathematical relationship is reported and discussed here.Entities:
Keywords: Tasso OnDemand; VAMS; dried blood; gefapixant
Mesh:
Substances:
Year: 2020 PMID: 32648772 DOI: 10.4155/bio-2020-0074
Source DB: PubMed Journal: Bioanalysis ISSN: 1757-6180 Impact factor: 2.681